252 related articles for article (PubMed ID: 26376109)
1. Protective effect of astragaloside IV on lipopolysaccharide-induced cardiac dysfunction via downregulation of inflammatory signaling in mice.
Zhao P; Wang Y; Zeng S; Lu J; Jiang TM; Li YM
Immunopharmacol Immunotoxicol; 2015; 37(5):428-33. PubMed ID: 26376109
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of ginsenoside Re on lipopolysaccharide-induced cardiac dysfunction in mice.
Chen RC; Wang J; Yang L; Sun GB; Sun XB
Food Funct; 2016 May; 7(5):2278-87. PubMed ID: 27074714
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy.
Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G
J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.
Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV Alleviates the Myocardial Damage Induced by Lipopolysaccharide via the Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB)/Proliferator-Activated Receptor α (PPARα) Signaling Pathway.
Zhang X; Li M; Wang H
Med Sci Monit; 2019 Sep; 25():7158-7168. PubMed ID: 31545785
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV protects against polymicrobial sepsis through inhibiting inflammatory response and apoptosis of lymphocytes.
Liu R; Jiang H; Tian Y; Zhao W; Wu X
J Surg Res; 2016 Jan; 200(1):315-23. PubMed ID: 26375505
[TBL] [Abstract][Full Text] [Related]
7. [Astragaloside IV regulates STAT1/IκB/NF-κB signaling pathway to inhibit activation of BV-2 cells].
He YX; Shi HL; Liu HS; Wu H; Zhang BB; Wu XJ; Wang ZT
Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(1):124-8. PubMed ID: 25993801
[TBL] [Abstract][Full Text] [Related]
8. α-Lipoic acid attenuates LPS-induced cardiac dysfunction through a PI3K/Akt-dependent mechanism.
Jiang S; Zhu W; Li C; Zhang X; Lu T; Ding Z; Cao K; Liu L
Int Immunopharmacol; 2013 May; 16(1):100-7. PubMed ID: 23562296
[TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin attenuates cardiac dysfunction in endotoxemic mice via the inhibition of nuclear factor-κB.
Zhai J; Guo Y
Biomed Pharmacother; 2016 May; 80():200-206. PubMed ID: 27133057
[TBL] [Abstract][Full Text] [Related]
10. Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a PI3K/Akt-dependent mechanism.
You W; Min X; Zhang X; Qian B; Pang S; Ding Z; Li C; Gao X; Di R; Cheng Y; Liu L
Shock; 2009 Jul; 32(1):108-17. PubMed ID: 19106822
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV inhibits NF- κ B activation and inflammatory gene expression in LPS-treated mice.
Zhang WJ; Frei B
Mediators Inflamm; 2015; 2015():274314. PubMed ID: 25960613
[TBL] [Abstract][Full Text] [Related]
12. MCP-1-induced protein attenuates endotoxin-induced myocardial dysfunction by suppressing cardiac NF-кB activation via inhibition of IкB kinase activation.
Niu J; Wang K; Graham S; Azfer A; Kolattukudy PE
J Mol Cell Cardiol; 2011 Aug; 51(2):177-86. PubMed ID: 21616078
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Astragaloside IV against LPS-Induced Endometritis in Mice through Inhibiting Activation of the NF-κB, p38 and JNK Signaling Pathways.
Wang F; Chen S; Deng L; Chen L; Huang Y; Tian M; Li C; Zhou X
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669661
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein.
Huang H; Lai S; Wan Q; Qi W; Liu J
Can J Physiol Pharmacol; 2016 May; 94(5):542-53. PubMed ID: 27070866
[TBL] [Abstract][Full Text] [Related]
15. Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism.
An R; Zhao L; Xi C; Li H; Shen G; Liu H; Zhang S; Sun L
Basic Res Cardiol; 2016 Jan; 111(1):8. PubMed ID: 26671026
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV-targeting miRNA-1 attenuates lipopolysaccharide-induced cardiac dysfunction in rats through inhibition of apoptosis and autophagy.
Wang Q; Yang X; Song Y; Sun X; Li W; Zhang L; Hu X; Wang H; Zhao N; Zhuang R; Xie X; Tang F; Wang H
Life Sci; 2021 Jun; 275():119414. PubMed ID: 33774032
[TBL] [Abstract][Full Text] [Related]
17. NRF2/HO-1 activation via ERK pathway involved in the anti-neuroinflammatory effect of Astragaloside IV in LPS induced microglial cells.
Li C; Yang F; Liu F; Li D; Yang T
Neurosci Lett; 2018 Feb; 666():104-110. PubMed ID: 29273400
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway.
Liu HS; Shi HL; Huang F; Peterson KE; Wu H; Lan YY; Zhang BB; He YX; Woods T; Du M; Wu XJ; Wang ZT
Sci Rep; 2016 Jan; 6():19137. PubMed ID: 26750705
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of PI3K-γ in a mouse model of sepsis-induced myocardial dysfunction.
Fan TT; Feng XY; Yang YZ; Gao F; Liu Q
Cytokine; 2017 Aug; 96():208-216. PubMed ID: 28458167
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D attenuates pro-inflammatory TNF-α cytokine expression by inhibiting NF-кB/p65 signaling in hypertrophied rat hearts.
Al-Rasheed NM; Al-Rasheed NM; Bassiouni YA; Hasan IH; Al-Amin MA; Al-Ajmi HN; Mohamad RA
J Physiol Biochem; 2015 Jun; 71(2):289-99. PubMed ID: 25929726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
